Literature DB >> 17149457

Ondansetron treatment in a child presenting with chronic intractable pruritus.

Chantal Frigon1, Joëlle Desparmet.   

Abstract

The case of a seven-year-old boy with chronic pruritus secondary to a giant congenital melanocytic nevus is presented. The pruritus did not respond to conventional antipruritic drug treatment, but responded to ondansetron, a selective antagonist of 5-hydroxytryptamine type 3 receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149457      PMCID: PMC2673141          DOI: 10.1155/2006/873870

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN: 1203-6765            Impact factor:   3.037


  26 in total

1.  Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

Authors:  R J Gralla; D Osoba; M G Kris; P Kirkbride; P J Hesketh; L W Chinnery; R Clark-Snow; D P Gill; S Groshen; S Grunberg; J M Koeller; G R Morrow; E A Perez; J H Silber; D G Pfister
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

Review 2.  ASHP Therapeutic Guidelines on the Pharmacologic Management of Nausea and Vomiting in Adult and Pediatric Patients Receiving Chemotherapy or Radiation Therapy or Undergoing Surgery.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  1999-04-15       Impact factor: 2.637

3.  Specific C-receptors for itch in human skin.

Authors:  M Schmelz; R Schmidt; A Bickel; H O Handwerker; H E Torebjörk
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

4.  Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.

Authors:  E V Balaskas; G I Bamihas; M Karamouzis; G Voyiatzis; A Tourkantonis
Journal:  Nephron       Date:  1998       Impact factor: 2.847

5.  Life-threatening blood loss from scratching provoked by pruritus in the bulky perineal nevocytoma variant of giant congenital melanocytic nevus in a child.

Authors:  Jing Feng; Aisha Sethi; Miguel Reyes-Múgica; Richard Antaya
Journal:  J Am Acad Dermatol       Date:  2005-08       Impact factor: 11.527

6.  Ondansetron for paediatric uraemic pruritus: a case report.

Authors:  Pankaj V Deshpande
Journal:  Pediatr Nephrol       Date:  2004-04-15       Impact factor: 3.714

7.  Intrathecal fentanyl-induced pruritus during labour: the effect of prophylactic ondansetron.

Authors:  J Wells; M J Paech; S F Evans
Journal:  Int J Obstet Anesth       Date:  2004-01       Impact factor: 2.603

8.  Prophylactic ondansetron does not reduce the incidence of itching induced by intrathecal sufentanil.

Authors:  Beverly Waxler; Shirley A Mondragon; Sonal N Patel; Kochuthresia Nedumgottil
Journal:  Can J Anaesth       Date:  2004 Aug-Sep       Impact factor: 5.063

9.  Ondansetron is effective to treat spinal or epidural morphine-induced pruritus.

Authors:  A Borgeat; H R Stirnemann
Journal:  Anesthesiology       Date:  1999-02       Impact factor: 7.892

Review 10.  Neurophysiology of pruritus: cutaneous elicitation of itch.

Authors:  Sonja Ständer; Martin Steinhoff; Martin Schmelz; Elke Weisshaar; Dieter Metze; Thomas Luger
Journal:  Arch Dermatol       Date:  2003-11
View more
  3 in total

1.  Neurocutaneous melanocytosis (melanosis).

Authors:  Martino Ruggieri; Agata Polizzi; Stefano Catanzaro; Manuela Lo Bianco; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-10-13       Impact factor: 1.475

2.  Ondansetron to treat pruritus due to cholestatic jaundice.

Authors:  Sarah Dillon; Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2013-07

3.  Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks.

Authors:  Martha M Rumore
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.